Relationship between blood glucose

合集下载

空腹血糖水平与胰岛素抵抗关系的分析

空腹血糖水平与胰岛素抵抗关系的分析

(FPG)的 升 高 ,体 重 指数 (BMI)、腰 围(WC)、三 酰 甘 油 (TG)、空 腹 胰 岛 素 (FINS)、2 h PG 逐 步上 升 ,与 FPG均具 有 统计 学 意 义 (P<0.05),但 6.1 mmol/L ̄<FPG<7.0 mmol/L组 与 5.6 mmol/L≤FPG<6.1
Yancheng City No.1 People s Hospital in Jiangsu Province from January 2008 to January 2009 were selected as the
study subjects.The subjects were divided into four groups according to the fasting blood sugar leve1.Basic physical examination and the oral glucose tolerance test were conducted and the 2-hour plasma glucose (2 h PC)was men- sured.The homeostasis model assessment insulin resistance index (HOMA-IR)and the homeostasis model assessment islet beta-cell function(HOMA-B)were calculated using the homeostasis model assessment(HOMA).The relationship
稳态模 式 评 估 法 (HOMA)计 算 稳态模 式 评 估 胰 岛素抵 抗 指数 (HOMA—IR)、胰 岛 B一细 胞功 能稳 态 模 型评 估

血药浓度和药效的关系英文作文

血药浓度和药效的关系英文作文

血药浓度和药效的关系英文作文The relationship between blood concentration and drug effectiveness is a crucial aspect of pharmacology and therapeutics. Blood concentration, often referred to as plasma concentration or serum concentration, refers to the amount of a drug present in the bloodstream at a given time. This concentration is directly linked to the drug's effectiveness, as it determines how much of the drugreaches its target site and how potent its therapeuticaction will be.Drug absorption, distribution, metabolism, andexcretion (ADME) are the four primary factors thatinfluence blood concentration. The rate and extent of drug absorption from the site of administration determine how quickly the drug enters the bloodstream. Distributionrefers to how the drug spreads throughout the body,reaching its target tissues and organs. Metabolism, the chemical transformation of the drug within the body, can either increase or decrease its blood concentration, depending on whether the metabolism leads to inactivationor activation of the drug. Excretion, the elimination ofthe drug from the body, is the final step in the ADME process, and it also affects blood concentration.Blood concentration is typically measured in micrograms per milliliter (μg/mL) or nanomoles per liter (nmol/L), depending on the drug and its properties. The optimal blood concentration for a drug is typically determined through clinical trials and pharmacokinetic studies, which aim to establish the dose-response relationship and identify the minimal effective concentration (MEC) and the maximal tolerable concentration (MTC).Drug effectiveness is influenced by both the blood concentration and the pharmacokinetic properties of the drug. A drug with a high affinity for its target site and a low clearance rate from the body is likely to be more effective at lower blood concentrations. Conversely, a drug with low affinity and high clearance may require higher blood concentrations to achieve the desired therapeutic effect.In addition to blood concentration, other factors such as the duration of drug exposure, the route of administration, and the patient's physiological status canalso affect drug effectiveness. For example, drugs administered intravenously typically achieve higher and faster blood concentrations than those administered orally. Similarly, patients with liver or kidney dysfunction may experience altered drug metabolism and excretion, leadingto changes in blood concentration and effectiveness.In summary, the relationship between bloodconcentration and drug effectiveness is complex and multifaceted. Understanding this relationship is crucialfor optimizing drug dosing, achieving desired therapeutic effects, and minimizing adverse effects. Future research in the field of pharmacology and therapeutics will continue to elucidate the intricacies of this relationship, leading to improved patient outcomes and more effective drug therapies. **血药浓度与药效的关系**血药浓度与药效之间的关系是药理学和治疗学中的关键方面。

探讨T2DM患者血糖及胰岛素敏感性与夜间血皮质醇水平的关系

探讨T2DM患者血糖及胰岛素敏感性与夜间血皮质醇水平的关系
LIU Chang-li, JIN Xiu-ping, WANG Ying, WANG Xiao-di
(The Affiliated Hospital of North China University of Science and Technology, Hebei, Tangshan)
mass index (BMI) divided into normal body mass index group (BMI < 25) 64 cases, the increase body mass index group (BMI≥25) in 82 cases. Results The increase body mass index group of cortisol levels(F), glycosylated hemoglobin (HbA1c) and insulin resistance index (HOMA-IR) were higher than the normal body mass index group ,P<0.05, the difference was statistically significant; The increase body mass index group, insulin sensitivity index (ISI) is lower than the normal body mass index group ,P<0.05,The difference was statistically significant; HbA1c was positive correlated with BMI, FPG, 2hPG, 0 point cortisol (P<0.05); HbA1c was negatively correlated with FIns, 2hIns, 2hC-P (P<0.05); BMI was positive correlated with HbA1c, 0 positive cortisol (P<0.05); BMI was negatively correlated with ISI (P<0.01); Conclusion The increased blood glucose level and decreased insulin sensitivity are associated with the increased cortisol levels at night on patients of the increase body mass index with type 2 diabetes. KEY WORDS: Diabetes mellitus; Type 2; Cortisol; Blood glucose; Insulin sensitivity

血清胱抑素及骨保护素水平与2型糖尿病患者并发非酒精性脂肪肝的相关性分析

血清胱抑素及骨保护素水平与2型糖尿病患者并发非酒精性脂肪肝的相关性分析

doi:10.3969/j.issn.1005-0264.2021.03.010血清胱抑素及骨保护素水平与2型糖尿病患者并发非酒精性脂肪肝的相关性分析刘丹赵冰程天英盘锦市中心医院消化科(辽宁盘锦,124000)摘要目的:探讨血清胱抑素C(CysC)及骨保护素(OPG)水平与2型糖尿病(T2DM)患者并发非酒精性脂肪性肝病(NAFLD)的相关性。

方法:选择2015年12月至2019年12月在我院治疗的T2DM并发NAFLD患者150例作为观察组,同时选择同期在我院就诊的T2DM未合并NAFLD患者100例作为对照组。

所有患者清晨空腹采集血液,检测空腹血糖(FPG)、胰岛素、总胆固醇(TC)、甘油三酯(TG),低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、丙氨酸氨基转移酶(ALT)、门冬氨酸氨基转移酶(AST)、血清同型半胱氨酸(Hcy)、CysC、OPG水平。

比较两组患者的各因子水平并探讨其与T2DM并发NAFLD的相关性。

结果:观察组患者的TC、TG、LDL-C、ALT、AST水平显著高于对照组,差异有统计学意义(P<0.05);观察组患者的FPG、餐后2h血糖(2h PG)、空腹胰岛素(Fins)、餐后2h胰.岛素(2h Ins)、胰岛素抵抗指数(HOMA-IR)水平显著高于对照组,差异有统计学意义(P< 0.05);观察组患者Hcy、CysC水平显著高于对照组,OPG水平显著低于对照组,差异有统计学意义(P<0.05);T2DM多因素Logistic 回归分析,NAFLD分别与HOMA-IR、TG、TC、LDL-C、Hcy、CysC呈独立相关性。

结论:T2DM合并NAFLD与胰.岛素抵抗、脂代谢紊乱、HCY、OPG等有较大关系,HOMA-IR、TC、TG、LDL-C、Hcy、CysC是T2DM并发NAFLD的危险因素,因此需要控制血糖、血脂水平,改善胰岛素抵抗,纠正Hcy、OPG水平,改善预后。

2型糖尿病患者血糖控制水平与血清肿瘤标志物相关性研究

2型糖尿病患者血糖控制水平与血清肿瘤标志物相关性研究

2型糖尿病患者血糖控制水平与血清肿瘤标志物相关性研究胡吉萍,朱丽丽,杜丙梅淄博市张店区妇幼保健院检验科,山东淄博255000[摘要]目的分析2型糖尿病患者血糖控制水平与血清肿瘤标志物相关性,为2型糖尿病合并恶性肿瘤患者的诊治提供依据。

方法选取2022年1—12月淄博市张店区妇幼保健院与淄博市中心医院诊断为2型糖尿病合并恶性肿瘤的患者200例作为研究对象,根据糖化血红蛋白的水平分为两组,观察组为血糖控制不佳糖化血红蛋白≥7.0%者102例,对照组为控糖佳糖化血红蛋白<7.0%者98例。

对比两组患者肿瘤标志物水平,Pearson相关性分析糖化血红蛋白与肿瘤标志物的相关性。

结果观察组血清神经元特异性烯醇化酶、癌胚抗原、糖链抗原19-9明显高于对照组,差异有统计学意义(P<0.05)。

糖化血红蛋白与血清神经元特异性烯醇化酶、癌胚抗原、糖链抗原19-9呈正相关(r=0.784、0.712、0.714,P<0.05)。

结论2型糖尿病患者血糖控制水平与血清肿瘤标志物水平呈正相关。

[关键词] 2型糖尿病;血糖控制水平;血清肿瘤标志物;相关性研究[中图分类号] R4 [文献标识码] A [文章编号] 1672-4062(2023)08(a)-0186-04Study on the Correlation between Blood Glucose Control Level and Serum Tumor Markers in Patients with Type 2 Diabetes MellitusHU Jiping, ZHU Lili, DU BingmeiDepartment of Laboratory, Zibo Zhangdian District Maternal and Child Health Hospital, Zibo, Shandong Province, 255000 China[Abstract] Objective To analyze the correlation between blood glucose control level and serum tumor markers in pa⁃tients with type 2 diabetes mellitus, and to provide a basis for the diagnosis and treatment of patients with type 2 dia⁃betes mellitus combined with malignant tumors. Methods From January to December 2022, 200 patients diagnosed as type 2 diabetes with malignant tumor in Zibo Zhangdian District Maternal and Child Health Hospita and Zibo Central Hospital were selected as the study subjects. According to the level of glycosylated hemoglobin, they were divided into two groups. The observation group was 102 patients with poor blood glucose control HbA1c≥7.0%, and the control group was 98 patients with good glucose control HbA1c<7.0%. Compared the levels of tumor markers between two groups of patients, and analyzed the correlation between HbA1c and tumor markers through Pearson correlation analy⁃sis. Results The NSE, CEA, and CA19-9 levels in the observation group were significantly higher than those in the control group, the difference was statistically significant (P<0.05). HbA1c was positively correlated with NSE, CEA, and CA19-9 (r=0.784, 0.712, 0.714, P<0.05). Conclusion The level of blood glucose control in patients with type 2 diabetes mellitus was positively correlated with the level of serum tumor markers.[Key words] Type 2 diabetes mellitus; Blood glucose control level; Serum tumor markers; Correlation study目前肿瘤标志物已成为恶性肿瘤筛查的一项主要检查[1]。

2型糖尿病患者血糖水平与肿瘤标志物CEA、CA199、AFP的相关性分析

2型糖尿病患者血糖水平与肿瘤标志物CEA、CA199、AFP的相关性分析

DOI:10.19368/ki.2096-1782.2023.09.0012型糖尿病患者血糖水平与肿瘤标志物CEA、CA199、AFP的相关性分析操燕红,周康淮安市淮安医院检验科,江苏淮安223200[摘要]目的分析2型糖尿病患者血糖水平与肿瘤标志物癌胚抗原(carcinoembryonic antigen,CEA)、糖类抗原199(Carbohydrate antigen199,CA199)与甲胎蛋白(Alpha fetoprotein,AFP)的相关性。

方法选取2019年10月—2022年10月淮安市淮安医院收治的106例2型糖尿病患者为糖尿病组,同时选择同期接受体检的100名健康人员作为对照组,比较两组血糖与肿瘤标志物指标水平,分析血糖水平对CEA、CA199与AFP的影响。

结果糖尿病组患者的FPG、HbA1c、CEA、CA199水平均高于对照组,差异有统计学意义(P<0.05)。

重度糖尿病患者的CEA、CA199水平均高于轻中度糖尿病患者,差异有统计学意义(P<0.05);相关性分析显示,2型糖尿病患者血糖水平与CEA、CA199呈现为正相关性(r=0.126、0.515,P=0.025、0.032),与AFP无明显相关性(P> 0.05)。

结论 2型糖尿病患者血糖水平和肿瘤标志物CEA、CA199表达存在明显关联,但与AFP表达无明显关联,可能受到2型糖尿病患者胰腺癌高发的影响。

[关键词]2型糖尿病;空腹血糖;餐后2 h血糖;癌胚抗原;糖类抗原199;甲胎蛋白[中图分类号]R4 [文献标识码]A [文章编号]2096-1782(2023)05(a)-0001-04Correlation Analysis of Blood Glucose Level and Tumor Markers CEA, CA199 and AFP in Patients with Type 2 Diabetes MellitusCAO Yanhong, ZHOU KangDepartment of Laboratory, Huai´an Hospital, Huai´an, Jiangsu Province, 223200 China[Abstract] Objective The correlation between blood glucose level and tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199) and alpha fetoprotein (AFP) in patients with type 2 diabetes was analyzed.Methods A total of 106 patients with type 2 diabetes admitted to Huai´an Hospital from of Huai´an city October 2019 to October 2022 were selected as the diabetic group, and 100 healthy people who underwent physical examination dur‐ing the same period were selected as the control group. The levels of blood glucose and tumor markers were compared between the two groups, and the effects of blood glucose levels on CEA, CA199 and AFP were analyzed. Results The levels of FPG, HbA1c, CEA and CA199 in the diabetic group were higher than those in the control group, and the dif‐ference was statistically significant (P<0.05). The levels of CEA and CA199 in patients with severe diabetes were higher than those in patients with mild to moderate diabetes, and the difference was statistically significant (P<0.05). Correlation analysis showed that the blood glucose level of patients with type 2 diabetes was positively correlated with CEA and CA199 (r=0.126, 0.515, P=0.025, 0.032), and had no significant correlation with AFP (P>0.05).Conclusion There was a significant correlation between blood glucose level and the expression of tumor markers CEA and CA199 in patients with type 2 diabetes, but no significant correlation with AFP expression, which may be affected by the high incidence of pancreatic cancer in patients with type 2 diabetes.[Key words] Type 2 diabetes; Fasting plasma glucose; 2-hour postprandial blood glucose; Carcinoembryonic antigen; Carbohydrate antigen 199; Alpha-fetoprotein[作者简介] 操燕红(1979-),女,本科,副主任技师,研究方向为医学检验。

为什么清晨反而比晚睡前的血糖水平高

为什么清晨反而比晚睡前的血糖水平高

为什么清晨反而比晚睡前的血糖水平高?将近半年多了,有两位朋友一直在问我,为什么她们清晨的空腹血糖比晚睡前还高?照理,一夜过去,又没吃东西,到早晨血糖应该更低才对呀。

我推想是内分泌系统在临晨发生小小兵乱,苦于没有证据,不可妄言。

今天发现了一篇好文章,答案找到了!既然已经帮朋友翻译过来了,就贴在这儿,供糖尿病和准糖尿病患友参考。

早晨空腹血糖高的原因有三个, 1.黎明现象, 这是身体自然的反应,是为了预备身体将要开始新的一天的工作所需要的能量,正常的人会分泌相应量的胰岛素来控制此时的血糖水平,有糖尿病的人,控制能力底了,所以血糖升高。

2。

Somogyi 效应,这是一位医生发现的现象,所以以他的名字命名。

当你半夜血糖水平降得太低时,身体为了保护自己,通过分泌其他激素而提高血糖水平,如果你睡觉前吃一点小点,就不会有这个问题。

3. waning insulin (胰岛素缺乏),通常发生在已经在用胰岛素治疗糖尿病的患者身上。

怎样分辨你是那一种原因造成的?以下是简易的方法。

1。

分别测定临晨3点,早晨的空腹血糖,如果3点时血糖正常,而清晨血糖较高,你可能是黎明现象。

2。

如果3点时血糖偏低,而清晨血糖较高,那么就是Somogyi 效应。

3。

如果3点时血糖比上床睡觉的时候,到早晨还持续高,说明是胰岛素缺乏。

原文如下:Rocky Morning Highs?With a little sleuthing you can identify—and fight—the causes of those rises in waking blood glucoseBy Terri D'Arrigo September 2008 Other Monitoring, BG and A1CSometimes diabetes doesn't make a whole lot of sense. Take those mornings when you wake up with blood glucose that's higher than it was when you went to sleep. You'd think that not eating for those seven or eight hours would give you lower blood glucose. But in fact, there are three reasons your blood glucose may be higher in the morning: the dawn phenomenon, the Somogyi effect, or waning insulin.The Dawn PhenomenonThe dawn phenomenon is a natural rise in blood glucose between the hours of 4:00 a.m. and 8:00 a.m., and it occurs because of hormonal changes in the body. "The body does several things to get ready for the day," says David S. Schade, MD, professor of medicine and chief of the Division of Endocrinology at the University of New Mexico School of Medicine in Albuquerque. "The body releases hormones like cortisol and growth hormone and the blood glucose rises. People without diabetes just secrete more insulin to handle the blood glucose, but for people with diabetes, the rise in blood glucose can be substantial."Schade notes that the effects of dawn phenomenon vary in each person, and your blood glucose may be higher on some mornings than on others. "You can do the same exercise and eat the same thing every day and have different blood glucose [levels] on different mornings because of dawn phenomenon," he says. "That makes it a little problematic." He adds that the scientific community is still figuring out the relationship between the release of these hormones and the rise in blood glucose. However, one thing scientists do know is that the liver produces glucose as part of the dawn phenomenon.Treatment for dawn phenomenon depends on how you treat your diabetes, says Stuart T. Haines, PharmD, BCPS, professor and pharmacotherapy specialist at the University of Maryland School of Pharmacy in Baltimore. If you take insulin, you may be able to adjust your dosing so that peak action occurs closer to the morning rise in your blood glucose. If you have type 2, diabetes pills provide options as well, he says: "You can add metformin to reduce the liver's glucose production."The Somogyi EffectThe Somogyi effect, named for researcher Michael Somogyi, PhD, who studied and first described it, is your body's response to a low that you had while you were sleeping. "This happens after low blood glucose induced by excess insulin, alcohol consumption, or not having had enough food," says Haines. "You have a low, and to counter that, your body responds in a rigorous way and cranks out a bunch of hormones, like glucagon." The body responds to those hormones by raising blood glucose—sometimes too much.You would treat this the opposite way of how you would treat dawn phenomenon, says Schade. "You could have a snack before you go to sleep or reduce your insulin infusion at night. If you take NPH, you can switch to an insulin that won't dip you down at 3:00 a.m." But wouldn't a low wake you up? Not necessarily, says Mindy Saenz, RD, LDN, CDE, clinical dietitian and diabetes educator in the Division of Endocrinology at the Brody School of Medicine at East Carolina University in Greenville, N.C. "You can sleep right through them," she says. "Nighttime lows are the most dangerous." She adds that it's a good idea to check your blood glucose if you wake up sweating or with headaches, as those are signs of a low.Waning InsulinThe dawn phenomenon and the Somogyi effect are pretty complicated hormonal stuff, but sometimes the simplest explanation is the correct one, Saenz says. Sometimes yourinsulin just runs out or wears off. Then it's a matter of you and your doctor adjusting your insulin regimen accordingly. "If it's insulin waning, you could look at splitting your basal insulin or taking it at a different time of the day," she says. "If you take NPH at supper, you could move it closer to bedtime."Before you and your doctor can adjust your diet or medications to handle high morning blood glucose, you have to know which of the three potential causes is the culprit. Experts agree that there's one simple, if somewhat inconvenient, way of figuring out what that might be: Check your blood glucose at 3:00 a.m. for several nights in a row. "You need to see where your blood glucose is at bedtime, at 3:00 a.m., and in the morning," says Saenz. She explains it this way:∙ If your blood glucose is fairly even between bedtime and 3:00 a.m., but then rises between 3:00 a.m. and morning, chances are you're experiencing dawn phenomenon.∙ If your blood glucose is low at 3:00 a.m., you're most likely experiencing the Somogyi effect.∙ If your blood glucose is higher at 3:00 a.m. than at bedtime and higher still in the morning, your insulin is probably waning.A continuous blood glucose monitor can go a long way toward helping you nab the perpetrator. These monitors record your blood glucose every few minutes around the clock, and they have alarms to alert you to highs and lows. The problem is that these monitors are expensive, and insurance coverage for them is hard to come by, says Schade. "We're all trying to get insurance to cover them, and some plans will, butMedicare won't," he says. "Some insurance companies will cover them if your doctor fills out a special form indicating why one would help you, but it's sporadic so check with your insurance company and see what the criteria are."If you have diabetes, chances are you'll experience the occasional high morning blood glucose. That's not something to fret about too much. But if it happens regularly, then it's time to call your doctor. "You should also suspect a problem when your morning blood glucose is the highest of the day, and when it is consistently high for the rest of the day after that," says Haines. Schade agrees. "If it's significant, it should be dealt with because those who have high blood glucose in the morning tend to have high blood glucose all day," he says. "It's important to recognize that and adopt a strategy to control it."。

GLUCOSEHOMEOSTASISAnOverview:葡萄糖稳态的概述

GLUCOSEHOMEOSTASISAnOverview:葡萄糖稳态的概述

Fig. 1: Variations in blood glucose and blood insulin levels correlated with periods of eating and fasting;
HOW DOES THE BODY NORMALLY DISPOSES OF HIGH LEVEL OF GLUCOSE IN BLOOD AFTER A MEAL?
• During prolonged fasting: • Blood glucose level usually decreases only slightly, but remains within normal range, • Brain and RBC are still actively metabolizing glucose, thus the blood glucose utilized must be replenished;
REGULATION OF BLOOD GLUCOSE DURING FASTING
How is Blood Glucose level regulated during fasting?
• Blood glucose level should normally remains constant, even if no food is consumed within 24-hour period;
• Increase in blood glucose level after a meal is immediately followed by increase in Blood Insulin level;
• Fig 1: Schematic representation of relationship between Blood Glucose and Insulin level in blood during periods of eating and fasting;

对1例代谢综合征合并抑郁焦虑状态患者的药学服务

对1例代谢综合征合并抑郁焦虑状态患者的药学服务

ChineseJoumalofNewDru¥s2008。

V01.17No.5・’’’,’''',,'’、.■’’.2药师与临床;。

-.y’t‘l‘●I●tt‘I‘t・对1例代谢综合征合并抑郁焦虑状态患者的药学服务陈碧翠L2,孙培红1,周颖1,崔一民1(1北京大学第一医院药剂科,北京100034;2北京大学药学院药事管理与临床药学系,北京100083)[摘要]目的:通过临床药师对1例代谢综合征合并抑郁焦虑状态的患者实施药学服务的过程,探讨药师在临床治疗中发挥的作用。

方法:针对具体病例,通过检索文献为患者治疗过程中药物的使用寻找支持依据,总结治疗经验,并对患者提出合理的药学监护措施及健康教育计划。

结果:临床药师为患者提供药学服务可以提高患者治疗的依从性,提高药物治疗水平。

结论:临床药师对药物疗效、相互作用、药物不良反应方面具有自身优势,以患者为中心的药学服务应成为医院药学的发展方向。

[关键词]代谢综合征;抗抑郁药;l临床药师;药学监护[中图分类号]R969.3;R971.43[文献标识码]A[文章编号]1003—3734(2008)05—0424一03PharmaceuticalcareforapatientwithmetabolicsyndromecomplicatedwithdepressivedisorderCHENBi—cuil’。

,SUNPei-hon91,ZHOUYin91,CUIYi—min‘(1DepartmentofPharmacy,FirstHospital,PekingUniversity,Beqing100034,China;2DepartmentofPharmaceuticalAdministrationandClinicalPharmacy,SchoolofPharmaceuticalSciences,PekingUniversity,Beijing100083,China)[Abstract]0bjective:Toinvestigatetheroleofclinicalpharmacistsinclinicalpracticethrou【ghanexperi—enceofpharmaceuticalcareforanoldpatientwithmetabolicsyndromecomplicatedwithdepressivedisorder.Methods:Basedonthemedicaldecisionbyliteratureretrievalandsummarizingexperienceduringthemedicalschedules,pharmacistsprovidedreasonablepharmaceuticalcareandhealtheducationtothepatient.Results:Clinicalpharmacistswerehelpfultoreinforcepatientcompliance,andtherebytooptimizethemedication.Conclu・sion:Clinicalpharmacistcanprovidetheknowledgeofefficacy,druginteractionandadversedrugreactionsinclinicalmedication,whichmaybecomeadevelopmentdirectionofhospitalpharmacy.[Keywords]metabolicsyndrome;antidepressantdrug;clinicalpharmacist;pharmaceuticalcare随着生活水平的提高,饮食结构的不合理和久坐的生活方式造成越来越多现代人集肥胖、胰岛素抵抗、血脂紊乱、高血压、动脉硬化性心脏病等多种心血管病危险因素于一身,即所谓的代谢综合征(metabolicsyndrome,MS),严重影响人类健康。

GDM_孕妇与非GDM_孕妇血糖、血脂指标异常与其分娩情况及胎儿结局的关系

GDM_孕妇与非GDM_孕妇血糖、血脂指标异常与其分娩情况及胎儿结局的关系

GDM孕妇与非GDM孕妇血糖、血脂指标异常与其分娩情况及胎儿结局的关系康海波 李启矿 陈静 陈漫霖(六盘水市妇幼保健院,贵州 六盘水 553000)【摘要】目的:探讨妊娠期糖尿病(GDM)孕妇与非GDM孕妇血糖、血脂指标异常与其分娩情况及胎儿结局的关系。

方法:选择2020年8月至2021年8月医院106例GDM孕妇作为研究对象,纳入GDM组,同期106例非GDM孕妇作为对照,纳入非GDM组,检测两组的血糖、血脂指标,统计两组的分娩情况及胎儿结局,分析GDM孕妇与非GDM孕妇血糖、血脂指标异常与其分娩情况及胎儿结局的关系。

结果:GDM组孕妇糖化血红蛋白(HbA1c)、空腹血糖(FBG)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)水平高于非GDM组孕妇,高密度脂蛋白胆固醇(HDL-C)低于非GDM组孕妇,孕妇不良分娩、不良胎儿结局发生率高于非GDM组孕妇,差异有统计学意义(P<0.05);不良分娩情况、不良胎儿结局的GDM孕妇HbA1c、FBG、TG、TC高于正常分娩情况、正常胎儿结局的GDM孕妇,差异有统计学意义(P<0.05);Logistic回归分析显示,HbA1c、FBG、TG、TC均与GDM孕妇不良分娩情况、不良胎儿结局有关(OR>1,P<0.05)。

结论:GDM孕妇与非GDM孕妇血糖、脂指标存在明显差异,GDM孕妇血糖血脂异常升高,会增加不良分娩情况及胎儿结局发生率。

【关键词】妊娠期糖尿病;血糖;血脂;分娩情况;胎儿结局【中图分类号】R714 【文献标识码】A 【文章编号】2096-5249(2023)21-0005-04The relationship between abnormal blood glucose and lipid levels, delivery status, and fetal outcomes in GDM and non GDM pregnant womenKang Hai-bo, Li Qi-kuang, Chen Jing, Chen Man-linLiupanshui Maternal and Child Health Hospital, Liupanshui 553000, Guizhou, China【Abstract】Objective: To explore the relationship between abnormal blood glucose and lipid indexes in pregnant women with diabetes mellitus (GDM) and non GDM women and their delivery and fetal outcomes. Method: 106 GDM pregnant women from the hospital from August 2020 to August 2021 were selected as the study subjects, and included in the GDM group. During the same period, 106 non GDM pregnant women were included as controls and included in the non GDM group. Blood glucose and lipid indicators were measured in both groups, and the delivery and fetal outcomes of the two groups were analyzed. The relationship between abnormal blood glucose and lipid indicators, delivery status, and fetal outcomes of GDM pregnant women and non GDM pregnant women was analyzed. Results The levels of glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in GDM group were higher than those in non GDM group, while high-density lipoprotein cholesterol (HDL-C) was lower than that in non GDM group. The incidence of adverse delivery and adverse fetal outcome in pregnant women was higher than that in non GDM group, with a statistically significant difference (P<0.05); The HbA1c, FBG, TG, and TC of GDM pregnant women with adverse delivery conditions and adverse fetal outcomes were higher than those with normal delivery conditions and normal fetal outcomes, and the difference was statistically significant (P<0.05); Logistic regression analysis showed that HbA1c, FBG, TG, and TC were all associated with adverse delivery and fetal outcomes in GDM pregnant women (OR>1, P<0.05). Conclusion: There is a significant difference in blood glucose and lipid indicators between GDM pregnant women and 作者简介:康海波(1984.08—),男,贵州省六盘水市人,本科学历,主管检验师,研究方向:临床检验医学。

急诊多发伤患者血糖变化与院内死亡率的关系研究

急诊多发伤患者血糖变化与院内死亡率的关系研究

DOI:10.1097/EJA.0000000000000324. [14]CHONG S E,MOHAMMAD ZAINI R H,WAN MOHD RUBI
I,et al.Difficult mask ventilation:simple step to make the impossible,possible![J].J Clin Anesth,2016,34:612614.DOI:10.1016/j.jclinane.2016.06.035. [15]JAYARAM K,GURAJALA I,DIDDI S,et al.Unrecognized epiglottic cyst:cause of difficult mask ventilation[J].J Anaesthesiol Clin Pharmacol,2015,31(4):566-567.DOI: 10.4103/0970-9185.169097. [16]于金辉,王艳.SMT- Ⅱ可视喉镜在急诊困难气道经口插管的 临 床 研 究[J]. 中 华 外 科 杂 志,2017,55(7):549-553. DOI:10.3760/cma.j.issn.0529-5815.2017.07.014. YU J H,WANG Y.Clinical study of SMT- Ⅱ video laryngoscope with difficult airway intubation in emergency department[J]. Chinese Journal of Surgery,2017,55(7):549-553.DOI: 10.3760/cma.j.issn.0529-5815.2017.07.014. [17]SCHÄUBLE J C,HEIDEGGER T.Erratum to:management of the difficult airway:overview of the current guidelines[J]. Anaesthesist,2019,68(1):29.DOI:10.1007/s00101-0180507-5.

鼻饲患者胃潴留的危险因素及护理措施

鼻饲患者胃潴留的危险因素及护理措施

神经系统疾病肠内营养支持操作规范共识(2011版)【10
】,认为神经疾病鼻饲患者验证胃潴留抽吸时>100ml即
为胃肠动力不全导致的胃潴留。另外有学者指出,在X线
下显示钡剂在4h后存留50%,或6h后未排空,也可提示
出现胃潴留【5】。
[9]刘晓岗.胃潴留的临床表现及诊断处理思路[J].中国全科医学,2012,15(6):43-45. [10]中华医学会肠外肠内营养学会神经疾病营养支持学组.神经系统疾病肠内营养支持操作规范共识(2011版)
读 鼻饲患者胃潴留的危险因素
书 报
及护理措施

ICU一区 侯艳利
鼻饲患者胃潴留的危险因素及护理措施
关键词
鼻饲 胃潴留 危险因素 护理措施
目录
主要 内容
前言 鼻饲患者易发胃潴留危险因素
胃潴留的判断 胃残留液的处理 胃潴留患者的护理措施
总结
1 前言
EN or PN
鼻饲
鼻饲是肠内营养的一种常用方法,2009年 美国危重症医学会和肠外肠内学会指南【1】推 荐,只要患者胃肠道功能完整或具有部分胃肠 道功能,就应该选择肠内营养。与肠外营养相 比,鼻饲喂养能更好地提供营养支持,降低病 死率及感染性并发症发生率,缩短住院天数和 提高患者生活质量。
2 鼻饲患者易发胃潴留危险因素
机械通气治疗•ຫໍສະໝຸດ 王军等【4】调查显示,机械通气治疗患者胃潴留发生率为71.3%,
与朱惠莉等【5】的报道一致,可能与机械通气患者上消化道不同程度
损害,导致胃底松弛延迟、胃窦部蠕动减少、独立幽门活动增多有关,
也可能与机械通气时气囊未完全封闭气道导致部分气体漏入胃部,导
致胃胀气、胃张力下降、胃排空延迟有关,或与呼吸末正压通气

2型糖尿病伴慢性牙周炎病人的血糖和炎性因子水平与牙周病变程度

2型糖尿病伴慢性牙周炎病人的血糖和炎性因子水平与牙周病变程度

2型糖尿病伴慢性牙周炎病人的血糖和炎性因子水平与牙周病变程度的相关性分析胡杉林(仙桃市第一人民医院口腔科,湖北仙桃433000)摘要:目的探讨血糖水平、肿瘤坏死因子-cx(TNF-a)、白细胞介素-1 (IL-1)、白细胞介素~6( IL~6)和前列腺素-2( PGE-2)炎性 因子水平与糖尿病伴慢性牙周炎病人牙周病变程度的相关性。

方法选择2型糖尿病伴慢性牙周炎病人102例。

检测血清 TNF-a、IL-l、IL~6和PGE-2。

检测血浆糖化血红蛋白(HbA〗C) 7JC平,以HbA〗C和胰岛素抵抗指数评估糖尿病病变程度,以牙 龈指数评估牙周炎病变程度。

分析血糖水平、TNF-a、IL-l、IL-6和PGE-2炎性因子水平与糖尿病伴慢性牙周炎病人疾病严重 程度的相关性。

结果轻、中、重度H b A'组牙龈指数等级分布差异有统计学意义(P <0. 05) ,Person相关性检验结果显示血 糖水平与牙龈指数等级存在显著正相关(P <〇.〇5)。

任意两组牙龈指数等级比较,胰岛素抵抗指数均差异有统计学意义,两 者呈显著正相关0=0.468,P =0.009)。

任意两组牙龈指数等级比较,血清TNF-a、IL-l、IL-6和PGE-2水平均差异有统计意 义(P < 0. 05),血清各炎性因子与牙龈指数等级差异有统计学意义(r = 0. 211,P = 0. 044; r = 0. 354,P = 0. 023; r = 0. 396, P = 0.017;r =0.538,P =0.011)。

结论2型糖尿病伴慢性牙周炎病人的血糖水平和血清TNF-a、IL-l、IL-6和PGE-2炎性因子水平与牙周病变程度呈显著正相关,治疗此类病人应该兼顾控制血糖和消除炎症。

关键词:2型糖尿病;牙周炎;血糖;炎性因子;病变程度doi :10. 3969/j. issn. 1009 - 6469. 2017.02.028The relationship between blood sugar and inflammatory factors with the severity ofdisease of type 2 diabetes mellitus and chronic periodontitisH U Shanlin{Department of Stomatology ,Xiantao First Peoples Hospital yXiantao y Hubei433000,China)Abstract : Objective To investigate the relationship between the levels of blood glucose, tumor necrosis factor alpha (T N F-a), interleukin-1 (IL-1 ) , interleukin-6( IL-6 ) and prostaglandin -2 (PG E-2) with the severity of disease in patients with diabetes mellitus and chronic periodontitis. Methods 102 cases type 2 diabetes mellitus complicated with chronic periodontitis in our hospital were selected. Serum TNF-a, IL-1 , IL-6and PGE-2 were detected. The level of plasma glycosylated hemoglobin (H b A^) was measured to evaluate the degree of diabetes mellitus with insulin resistance index. The degree of periodontitis was evaluated with gingival index. The relationship between the levels of blood glucose, TNF-a, IL-1 , IL-6and PGE-2 inflammatory factors and the severity of disease in patients with diabetes mellitus and chronic periodontitis was analyzed. Results In mild, moderate and severe HbAlc group, there was a significant difference in the gingival index grades. The result of Person correlation test showed that there was a significant positive correlation between the level of blood glucose and the gingival index ( P < 0. 05 ). There were significant differences in the indexes of the two groups ( P <0. 05) and the two groups were significantly positively correlated ( r = 0. 468 ,P = 0. 009). Compared with the gingival index between any of two groups of level, there were significant difference of serum TN F-a, IL-1 , IL-6and PGE-2 ( P < 0. 05 ) . The serum inflammatory factor and the gingival index level showed significant positive correlation ( r= 0. 211 ,P =0. 044 ;r= 0. 354 , P = 0. 023 ;r= 0. 396 , P = 0. 017 ; r= 0. 538 , P = 0. 011 ). Conclusion The level of blood glucose and serum levels of TN F-a, IL-1 , IL-6 , PGE-2 and were positively correlated with the de­gree of periodontal disease in type 2 diabetes mellitus combined periodontits patients. Treatment of such patients should take into account both the control of blood sugar and the elimination of inflammation.Key words:Type 2 diabetes mellitus;Periodontitis;Blood sugar;Inflammatory factors;Degree of pathological changes糖尿病是以血糖升高为主要特征的慢性代谢 性紊乱性疾病,长期的高血糖状态会导致体内微炎 性反应,引起心血管疾病的发病率升高。

血糖控制与糖尿病足关系的研究进展

血糖控制与糖尿病足关系的研究进展

右江医学 2019 年第 47 .卷第 11 期 Chin 藻泽藻 Youji 葬灶早 M 藻凿蚤糟葬1 Journal 2019,Vol. 47 No. 11 .愿01・专家论坛血糖控制与糖尿病足关系的研究进展刘贤彬'袁2,吴标良3(右江民族医学院1.附属医院内分泌科,2.研究生学院,广西百色533000):专家介绍]吴标良,教授、主任医师,医学博士,美国哈佛大学医学院留学归国学者,博/硕士研究生导师,右江民族医学院附属医院内分泌科副主任。

主要从事糖尿病及其各种急慢性并发症的基础及临床研究。

现为中国中医外治学会委员,广西内分泌学会、糖尿病学会、老年学会、骨质疏松学会委员,百色市内分泌学会副主任委员。

共发表科研论文30余篇,其中中文核心10余篇,SCI 收录3篇。

主持国家自然 科学基金2项、广西自然科学基金2项,主持、参与其他国家级、省部级、市厅级研究课题近10项,主编、参编教材/专著3部。

曾获广西科技进步二等奖、百色市科技进步一等奖等多项科研奖励遥【摘要】糖尿病足是糖尿病中严重的慢性并发症,是糖尿病非外伤性截肢的主要病因,是导致患者残疾、死亡的主要原因之 一。

长期高血糖状态可导致炎症反应、相关细胞生长因子减少、血管病变及神经结构功能损伤。

该文对血糖控制与糖尿病足 有关系的研究现状进行综述。

揖关键词】糖尿病足;血糖控制;炎症;细胞生长因子;血管病变;神经病变中图分类号:R587.2文献标志码:A D0I :10. 3969/j .issn. 1003-1383. 2019. 11. 001Research progress on the relationship between blood glucose control and diabetic footLIU Xianhin 1,2 袁 WU Biaoli(mg [k(1. Department of Endocrinology of Affiliated Hospital ,2. Graduate School ,Youjiang Medical University for Nationalities 袁 Baise 533000, China)揖 Abstract ] Diabetic foot is a severe chronic complication of diabetes 袁 main cause of non-traumatic amputation of diabetic limbs 袁 andone of the main causes of disability and death. Long-term hyperglycemia can lead to inflammation 袁 reduction in growth factor 袁 vasculopa ­thy and neurological structural and functional impairment. This article reviews the research status of the relationship between blood sugarcontrol and diabetic foot.揖 Key words ] diabetic foot ; blood glucose control ; inflammation ; cell growth factor ; vasculopathy ; neuropathy近年来随着经济发展,生活方式改变,我国糖尿病患病率逐年上升,国内一项流行病学研究结果指出,我国糖尿病患病率已达10. 4%[1] 遥而糖尿病患者发生足部溃疡的风险达25%咱2暂遥糖尿病足定义为 下肢神经功能异常和血管病变相关的足溃疡、感染 和(或)深部组织损伤。

血清骨钙素水平与2型糖尿病周围神经病变的关系

血清骨钙素水平与2型糖尿病周围神经病变的关系

·糖尿病与并发症·DIABETES NEW WORLD糖尿病新世界糖尿病新世界2021年2月40年来,我国糖尿病患病率从1980年的0.67%升至2013年的10.40%[1],糖尿病慢性并发症的发病率亦逐年升高。

近些年研究表明糖尿病患者的微血管并发症与骨质疏松及骨折有关,而骨代谢标志物在评估骨质疏松方面较骨密度更敏感,但目前糖尿病微血管并发症与骨代谢标志物关系的研究仍较少,骨代谢标志物中具有代表意义的是骨钙素[2],为骨细胞外基质的重要组成成分,是评估骨代谢和骨转化的生化指标,而糖尿病周围神经病变(DPN)是发病率较高的糖尿病微血管并发症。

该研究选取2018年7月—2019年12月的DOI:10.16658/ki.1672-4062.2021.04.169血清骨钙素水平与2型糖尿病周围神经病变的关系范媛媛,李子玲内蒙古包钢医院内分泌科,内蒙古包头014010[摘要]目的分析2型糖尿病患者血清骨钙素水平与糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)的关系。

方法选取2018年7月—2019年12月于内蒙古包钢医院内分泌科就诊的T2DM 患者120例,将其分为2型糖尿病无周围神经病变组(NDPN 组,n=60)、2型糖尿病合并周围神经病变组(DPN 组,n=60)。

同时从医院体检中心选取非糖尿病健康人30名作为正常对照组(NC 组)。

收集受试者的临床资料,检测其空腹血糖、糖化血红蛋白、血脂、血钙、25羟维生素D、空腹胰岛素,计算稳态模型胰岛素抵抗指数(HOMA-IR)。

采用电化学发光方法测定骨钙素水平。

结果①DPN 组血清骨钙素水平均低于NDPN 组及NC 组,骨钙素水平由低到高依次为DPN 组<NDPN<NC 组,差异有统计学意义[(9.48±4.12)、(17.84±7.42)、(18.07±3.41)ng/mL(F =16.983,P<0.05)]。

2_型糖尿病血糖波动指标与体脂分布的关系

2_型糖尿病血糖波动指标与体脂分布的关系

2型糖尿病血糖波动指标与体脂分布的关系赵娟,关雅心,梁丽芳,白川民,张雪晴,念馨,吴斌昆明医科大学第一附属医院内分泌一科,昆明650000摘要:目的 探讨2型糖尿病(T2DM )患者血糖波动指标与体脂分布的关系。

方法 收集T2DM 患者102例,根据2017年《中国糖尿病患者血糖波动管理专家共识》计算出各项血糖波动指标,测量腹部皮下脂肪组织(SAT )和内脏脂肪组织(VAT )面积。

根据VAT 面积分为VAT<100 cm 2组和VAT≥100 cm 2组,比较两组间血糖波动指标与体脂肪分布和各项生化指标的差异,Pearson 相关分析法分析血糖波动指标与体脂肪分布指标的相关性。

结果 与VAT<100 cm 2组相比,VAT≥100 cm 2组身高、体质量、体质量指数(BMI )、体脂指数(FMI )、VAT 、SAT 、VAT /SAT 、腰围、臀围、胰岛素抵抗指数(HOMA -IR )升高(P 均<0.05)。

Pearson 相关分析显示,血糖水平标准差与VAT /SAT 、HbA 1c 、HOMA -IR 呈正相关(r 分别为0.228、0.283、0.260,P 均<0.05);餐后血糖波动幅度与胰岛β细胞功能(HOMA -β)呈负相关(r =-0.248,P <0.05);最大血糖波动幅度与VAT /SAT 、HbA 1c 、HOMA -IR 呈正相关(r 分别为0.210、0.293、0.260,P 均<0.05);血糖平均值与HbA 1c 、HOMA -IR 呈正相关(r 分别为0.516、0.412,P 均<0.05),与胰岛素敏感指数(HOMA -ISI )呈负相关(r =-0.369,P <0.05)。

结论 血糖波动与VAT /SAT 、HbA 1c 、HOMA -IR 呈正相关;与HOMA -β、HOMA -ISI 呈负相关;内脏脂肪面积越大血糖波动越大,SAT 面积越大血糖波动越小,减少VAT 和/或增加SAT 可降低T2DM 患者血糖波动。

血糖、血钙对急性重症胰腺炎患者预后影响的交互作用及预测效能研究

血糖、血钙对急性重症胰腺炎患者预后影响的交互作用及预测效能研究

◇基础研究◇摘要目的:探讨血糖、血钙对急性重症胰腺炎(SAP )患者预后影响的交互作用,并分析其对预后的预测效能。

方法:选取2019年9月至2022年10月本院收治的107例SAP 患者为研究对象,根据28d 内预后情况分为不良组、良好组。

比较两组治疗前、治疗3d 后、治疗7d 后血糖、血钙、改良Marshall 评分、床旁急性胰腺炎严重度评分(BISAP ),并分析血糖、血钙与改良Marshall 评分、BISAP 评分相关性。

比较不同血钙患者血糖水平。

Cox 回归分析预后的相关影响因素。

使用交互作用系数γ、相对危险度(RR )值分析血糖、血钙对预后影响的交互作用是否存在及其类型。

受试者工作特征曲线(ROC )分析血糖、血钙对预后的预测效能。

结果:不良组治疗后血糖、改良Marshall 评分、BISAP 评分高于良好组,血钙低于良好组(P <0.05);治疗3d 后、治疗7d 后血糖与改良Marshall 评分、BISAP 评分呈正相关,而血钙与之相反(P <0.05);血钙降低患者血糖水平高于血钙正常患者(P <0.05);血钙降低对血糖升高的效应具有正向交互作用(P <0.05);治疗3d 后、治疗7d 后血糖联合血钙预测预后的AUC 大于单独指标预测(P <0.05)。

结论::SAP 患者血糖、血钙与病情严重程度有关,血糖、血钙对SAP 患者预后的预测存在交互作用,联合检测其水平对SAP 患者预后具有一定预测效能。

关键词急性重症胰腺炎;血糖;血钙;预后;交互作用;预测中图分类号:R576文献标志码:A文章编号:1009-2501(2023)11-1227-08doi :10.12092/j.issn.1009-2501.2023.11.004急性重症胰腺炎(severe acute pancreatitis ,SAP )属于临床常见急腹症,临床表现为上腹部急性疼痛、发热、恶心等,我国SAP 病死率为20%~30%[1]。

中西医联合治疗JAK2V617F阳性原发性血小板增多症的临床疗效

中西医联合治疗JAK2V617F阳性原发性血小板增多症的临床疗效

·17·安徽卫生职业技术学院学报 2021年20卷第1期中西医联合治疗JAK2V617F阳性原发性血小板增多症的临床疗效肖 红 艾 国 王 琥 何颖颖 宋 琴 周晨晨【中图分类号】 R558.3 【文献标识码】 A 【文章编号】 1671-8054(2021)01-0017-03【摘 要】 目的:探讨中西医联合治疗JAK2V617F阳性原发性血小板增多症的临床疗效。

方法:将住院与门诊收治的JAK2V617F阳性原发性血小板增多症患者56例作为研究对象,随机分为对照组(27例)和实验组(29例),对照组患者接受α-干扰素进行治疗,实验组患者在对照组治疗基础之上加用中药汤剂进行治疗,对比两组患者药效临床有效率及血小板计数减少程度。

结果:两组患者临床有效率、血小板计数减少对比,差异均有统计学意义(P<0.05)。

结论:临床可对JAK2V617F阳性原发性血小板增多症进行中西医联合治疗,疗效满意,不良反应少且不易复发。

【关键词】 JAK2V617F阳性 原发性血小板增多症 中西医联合 活血化瘀原发性血小板增多症(Primary thrombocytosis,PT)亦称特发性血小板增多症,为多能造血干细胞克隆性增殖性疾病。

其病因及发生机制目前尚不完全清楚,但大部分PT患者的骨髓细胞中可能出现JAK2V617F点突变,而研究表明该基因突变可致高肿瘤细胞负荷,出现的血栓事件,疾病转化等与之相关[1]。

在临床中出血及血栓的相关并发症严重危害人类的健康。

目前,西医主要用羟基脲、干扰素及芦可替尼等药物来降低血小板数量,减少相关出血及栓塞相关风险,但是该类疾病易复发,长期应用羟基脲、干扰素及芦可替尼会导致一系列的不良反应,会加重患者的心理负担。

本病在中医属于“血积”“血瘀”病范畴,中医认为禀赋薄弱、外感六淫、劳倦过度等致阴阳失衡,脏腑气血失调失衡,气滞血瘀等致骨髓增殖偏胜,血实血瘀,血液积聚而发为本病。

老年糖尿病患者不同糖化血红蛋白水平与全天血糖水平的相关性分析

老年糖尿病患者不同糖化血红蛋白水平与全天血糖水平的相关性分析

老年糖尿病患者不同糖化血红蛋白水平与全天血糖水平的相关性分析程天一1* 王俊2 闻捷1(1.上海市黄浦区打浦桥街道社区卫生服务中心全科,上海 200023;2.上海市徐汇区龙华街道社区卫生服务中心全科,上海 200232)摘 要 目的:探讨老年2型糖尿病患者不同糖化血红蛋白与日内不同时段血糖水平的相关性。

方法:收集2013年1月至2014年1月住院的老年2型糖尿病患者120例,用毛细血管血糖监测2个月(第1个月4点血糖,第2个月7点血糖),同时在第2个月末监测糖化血红蛋白水平、血脂和肾功能,并根据糖化血红蛋白水平将患者分成A组(≤7%)68例、B组(7%~8%)33例和C组(≥8%)19例。

分析患者不同性别、不同水平糖化血红蛋白与日内不同时段血糖、血脂、肾功能之间的关系。

结果:三组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、肌酐(Cr)、尿素氮(BUN)水平检测显示,B组均大于A组(P<0.05),C组大于A、B组(P<0.05)。

三组糖化血红蛋白、早餐后、午餐前、晚餐后血糖水平B组均大于A组,C组大于A、B组(P<0.05);在空腹、晚餐前及睡前血糖测定显示,C 组大于A、B组(P<0.05),A、B组间无差异。

经Pearson检验糖化血红蛋白与不同时段血糖、肾功能、血脂呈正相关性(P<0.01),而与病程、年龄、性别无相关性(P>0.05)。

除年龄外,不同性别之间的糖化血红蛋白、肾功能、血脂、病程差异均无统计学意义(P>0.05)。

结论:老年2型糖尿病患者糖化血红蛋白与各时段血糖呈正相关性,亦与肾功能、血脂呈正相关性,除空腹、睡前血糖外,余日内各时段血糖、LDL-C、TG、TC及肾功能均随糖化血红蛋白水平升高而逐渐升高。

因此,控制血糖的同时要对血脂、肾功能进行监测和干预治疗。

关键词 2型糖尿病;糖化血红蛋白;毛细血管血糖中图分类号:R587.1 文献标志码:A 文章编号:1006-1533(2021)02-0020-04Correlation analysis of different glycosylated hemoglobin levels and whole day blood glucose levels in the elderlydiabetic patientsCHENG Tianyi1, WANG Jun2, WEN Jie1(1. General Practice Department of Dapuqiao Community Health Service Center, Huangpu District, Shanghai 200023, China;2. GeneralPractice Department of Longhua Community Health Service Center, Huangpu District, Shanghai 200232, China)ABSTRACT Objective: To investigate the association between different glycosylated hemoglobin and blood glucose levels in different periods of the day in the elderly patients with type 2 diabetes. Methods: One hundred and twenty elderly patients with type 2 diabetes who were hospitalized from January 2013 to January 2014 were collected, blood glucose was monitored by capillary blood glucose for 2 months(four times blood glucose in the first month and seven times blood glucose in the second month), meanwhile, glycosylated hemoglobin level, blood lipids and renal function were monitored at the end of the second month and according to glycosylated hemoglobin levels they were divided into group A(≤7%) with 68 cases, group B(7%~8%) with 33 cases, and group C(≥8%) with 19 cases. The relationship between blood glucose, blood lipid and renal function of patients with different gender and different levels of glycosylated hemoglobin were analyzed. Results: The levels of total cholesterol(TC), triglycerides(TG), low-density lipoprotein(LDL-C), creatinine(Cr), and urea nitrogen(BUN) in the three groups showed that group B was greater than group A(P<0.05) and group C was larger than group A and group B(P<0.05).The blood glucose levels of glycosylated hemoglobin, after breakfast, before lunch, and after dinner showed that group B was *通信作者:程天一。

观察分析老年人空腹血糖与糖化血红蛋白及尿微量蛋白的关系

观察分析老年人空腹血糖与糖化血红蛋白及尿微量蛋白的关系

观察分析老年人空腹血糖与糖化血红蛋白及尿微量蛋白的关系【摘要】:目的观察分析老年人空腹血糖与糖化血红蛋白、尿微量蛋白之间的关系。

方法抽取2018年1月-2019年11月来我院进行常规体检的老年人294例作为研究对象,分正常组100例,空腹血糖调节受损组82例,糖尿病组64例,重症糖尿病组48例。

分别对其空腹血糖(FPG)、糖化血红蛋白(HbAlc)以及尿微量蛋白(U-mAlb)水平进行测定,并分析老年人的空腹血糖值与糖化血红蛋白、尿微量蛋白水平间的关系。

结果与正常组比较,空腹血糖调节受损组、糖尿病组以及重症糖尿病组FBG、HbAlc以及U-mA1b水平均明显升高,差异有统计学意义(P<0.05)。

随着血糖水平的逐渐升高,患者HbAlc以及U-mA1b水平均逐渐升高,差异有统计学意义(P<0.05)。

结论空腹血糖值与糖化血红蛋白、尿微量蛋白水平有一定相关性,可以反映老年人糖代谢紊乱、糖尿病及肾功能损伤,具有临床应用价值。

【关键词】:空腹血糖;糖化血红蛋白;尿微量蛋白;老年人;糖尿病;关系The relationship between fasting blood glucose and glycosylated hemoglobin and urinary microprotein was observed and analyzed【 abstract 】 : objective to observe and analyze the relationship between fasting blood glucose and glycosylated hemoglobin and urinary microprotein in the elderly.Methods: from January 2018 to November 2019, 294 elderly patients who came to our hospital for routine physical examination were selected as the study subjects, including 100 patients in the normal group, 82 patients in the impaired fasting blood glucose regulation group, 64 patients in the diabetes group, and 48 patients in the severe diabetes group.Fasting blood glucose (FPG),glycosylated hemoglobin (HbAlc) and urinary microprotein (u-malb) levels were measured, and the relationship between fasting blood glucose and glycosylated hemoglobin and urinary microprotein levels was analyzed.Results compared with the normal group, FBG, HbAlc and u-ma1b levels were significantly increased in the groups with impaired fasting glucose regulation, the diabetes group and the severe diabetes group (P<0.05).With the gradual increase of blood glucose level, patients' HbAlc and u-ma1b levels gradually increased, and the difference was statistically significant (P<0.05).Conclusion there is a certain correlation between fasting blood glucose and glycosylated hemoglobin and urinary microprotein level, which can reflect the glucose metabolism disorder, diabetes and renal injury in the elderly, and has clinical application value.【key words 】: fasting blood glucose;Hba1c;Urinary microprotein;The elderly;Diabetes;Relationship between在我国老龄化程度不断深化的情况下,老年人的健康状态也应受到更多的关注。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Abstract.–OBJECTIVE:To evaluate the rela-tionship between blood glucose fluctuation and macrovascular dysfunction.PATIENTS AND METHODS:Eighty-eight type 2diabetes mellitus (T2DM)patients with or without coronary heart disease (CHD)and 30healthy con-trol subjects were recruited.Glycosylated hemo-globin A1c (HbA1c),fasting insulin (FIns),and C-reaction protein (CRP)and some other general clinical variables were measured.A 72-hour con-tinuous glucose monitoring (CGM)and brachial artery endothelium-dependent flow-mediated dila-tion (FMD)assessment were performed.The glu-cose excursion,MAGE (mean amplitude of glycemic excursions),LAGE (largest amplitude of glycemic excursions),MPPGE (mean postprandial glycemic excursions),MODD (absolute means of daily differences),and IAUC70(incremental area under the curve below 70mg/dl)during the CGM were analyzed.Correlations between the various variables were analyzed.RESULTS:Enhanced blood glucose fluctuation was observed in T2DM patients with CHD as compared to other participants.And blood glu-cose fluctuation was correlated with FMD,CRP and HOMA-IR.CONCLUSIONS:Blood glucose fluctuation is an important factor that affects inflammatory re-sponse and possibly induces CHD in T2DM pa-tients.Key Words:Type 2diabetes mellitus,Coronary heart disease,Continuous glucose monitoring system,Macrovascu-lar endothelial dysfunction,C-reactive protein.IntroductionCoronary heart disease (CHD)is one of the most common complications of Type 2diabetes mellitus (T2DM).Evidence-based medicine stud-Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences Relationship between blood glucosefluctuation and macrovascular endothelial dysfunction in type 2diabetic patients with coronary heart diseaseX.-G.ZHANG,Y .-Q.ZHANG 1,D.-K.ZHAO,J.-X.WU,J.ZHAO,X.-M.JIAO,B.CHEN,X.-F .LVDepartment of Endocrinology,General Hospital of Beijing Military Area,Beijing,PR China 1China National Institute of Standardization,Beijing,PR ChinaCorresponding Author:Xiaofeng Lv,MD;e-mail:xiaofenglv7966@3593ies have shown that control of glycosylated hemo-globin A1c (HbA1c)may reduce the occurrence of microvascular complications significantly but not cardiovascular diseases.This suggests that the prevalence of macrovascular complications may not be evaluated by measuring HbA1c alone 1.It has been reported that blood glucose fluctuation is significantly associated with complications of T2DM 2-5.Research demonstrated by Jiao et al in-dicated that blood glucose fluctuation influence lower-extremity vascular disease in type 2diabetes and related with diabetic macroangiopathy.Mean amplitude of glycemic excursion (MAGE),firstly proposed in 1970by Service et al 5,changes the overall level of blood glucose independently.As a result,MAGE is constantly used to assess glycemic variability 7,8.It has been demonstrated that an intermittent exposure to high glucose induces more pro-nounced metabolic changes and cytotoxicity than a constant exposure 8.This is because intermittent high glucose is more effective in triggering the generation of nitrotyrosine,activating the expres-sion of protein kinase C (PKC)and inducing the expression of adhesion molecules (ICAM-1,VCAM-1and E-selectin)than constant high glu-cose 9,10.Additionally,intermittent high glucose is capable of enhancing oxidative stress,inducing cell apoptosis as well as reducing the synthesis of vascular relaxing factor (e.g.NO)as demonstrat-ed in cultured cells 12-14.Changes in vessel wall shear stress induced by increased blood flow may result in NO release from vascular endothelial cells.NO subsequently activates guanylate cyclase in smooth muscle cells,leading to an elevation in cyclic guanosine monophosphate (cGMP).Eventually,brachial artery flow-mediated endothelium-dependent va-2014;18:3593-3600sodilation(FMD)occurs in the smooth muscle. Previous studies have demonstrated that brachial artery FMD is closely related to vasodilation of the coronary artery and the injury severity of the brachial artery is closely related to vasodilation of the atherosclerotic carotid and the atherosclerotic coronary,these suggesting that brachial artery FMD may be used as an indirect indicator of the coronary and systemic vascular functions15,16.In the present study,we observed that blood glucose fluctuation was more pronounced in T2DM patients with CHD.Glycemic fluctuation may be one of the factors that influence brachial artery FMD.An increase in C reactive protein (CRP)concentration associated with glucose fluctuation may result in the decline of brachial artery FMD.Patients and Methods SubjectsType2diabetes mellitus(T2DM)patients aged between50and70years were consecutive-ly admitted to the General Hospital of Beijing Military Area December2010to November 2011.The study protocol including screening, treatment,and data collection were approved by the Institutional Ethics Committee.Written in-formed consent was obtained from all subjects. The provisions of the Declaration of Helsinki were strictly followed.Inclusion and Exclusion Criteria Coronary arteriography was adopted if the ex-amination performed in the last2months.Coro-nary heart disease was accordingly diagnosed if the left main artery showed≥30%stenosis or at least one branch of three major coronary arteries showed≥50%stenosis.The diagnosis of T2DM was adopted according to the diagnostic criteria of American Diabetes Association(ADA)in2010. Patients should have regular diet,exercise and medication,stable hypoglycemic scheme in the last three months and no extreme blood biochemi-cal indicators of hepatic and renal function.The exclusion criteria were:(1)acute complication of diabetes in the last six months;(2)post-menopausal women taking estrogen;(3)eye dis-ease caused by hypertension,thromboangioitis obliterans or Takayasu arteritis(caused by the non-diabetic vascular disease)and other diseases that could affect vascular endothelial function;(4) acute coronary syndrome or acute brain damage in the last month;(5)hepatic or renal dysfunction;(6)MI(myocardial infarction),unstable angina, stroke or a transient ischaemic attack;and(7)evi-dence of severe hepatic or renal disease. Demographic Data CollectionDemographic data and information on medica-tions prior to admission were recorded.After fasting for12hours,3-5ml venous blood was sampled,mixed and placed at room temperature. Hepatic and renal function parameters and lipid metabolism indicators were determined with an automatic biochemical analyzer(Dxc600,Beck-man,Fremont,CA,USA).Fasting plasma glu-cose(FPG)was measured by glucose oxidase method.Affinity chromatography detection was carried out on a glycated hemoglobin analyzer (D10,Bio-Rad,Hercules,CA,USA)to deter-mine HbA1c concentration.Radioimmunoassay was used for fasting insulin(FIns)determination. C-reaction protein(CRP)in the plasma was mea-sured using an enhanced turbidimetric im-munoassay.Non-anticoagulant blood was cen-trifuged at3,500rpm for10min and the same in-dicators in the serum were detected for calibra-tion and quality control.Insulin resistance index (IR)was calculated by the Homeostasis Model as previously described17:HOMA-IR=Fins (µIU/mL)×FPG(mmol/L)/22.5.Coronary an-giography was performed by coronary angiogra-phy equipment(General Electric,USA). Continuous Glucose Monitoring Continuous glucose monitoring(CGM)was performed at least one week after coronary an-giography.A CGM system(CGMS)sensor (Medtronic,Northridge,CA,USA)was inserted into all participants by the same specialized nurse at8:00-9:00AM on the first day of hospi-talization.First CGMS calibration by finger stick blood glucose was performed1h after the procedure initialization.Subsequently,calibra-tion was performed four times daily for each subject.The interval between two calibrations was not exceeding8hours.Events such as eat-ing,exercise,taking hypoglycemic drugs and low blood glucose reactions that might affect blood glucose fluctuation were digitally record-ed.If no abnormal CGMS situation was ob-served,CGM was performed for72consecutive hours.Data on mean blood glucose(MBG), standard deviation of blood glucose(SDBG), mean amplitude of glycemic excursions (MAGE),largest amplitude of glycemic excur-X.-G.Zhang,Y.-Q.Zhang,D.-K.Zhao,J.-X.Wu,J.Zhao,X.-M.Jiao,B.Chen,X.-F.Lv 3594Blood glucose fluctuation in T2DM with CHD3595were allocated to T2DM2group.Thirty (15male,15female)healthy individuals were in-cluded as control subjects (NC group).Clinical Characteristics,CGM,FMD and CRPIn the NC group,blood glucose was within the normal range with a minor fluctuation.In con-trast,significant blood glucose fluctuations were observed in the two (T2DM1and T2DM2)dis-ease groups.When the two disease groups were compared,a larger degree of blood glucose fluc-tuation was detected in the T2DM2group than that in T2DM1group (p <0.05).Showed in Table I are the clinical data of subjects in the 3groups.There was no signifi-cant difference (p >0.05)either in the average age (or in the use of hypoglycemic drugs be-tween the 3groups.No extreme blood pressure was measured in any of the pared with the NC group,T2DM1and T2DM2groups had significantly higher levels of SDP,LDL-C,FBG,HbA1c,HOMA-IR,MAGE,LAGE,MPPGE,MODD,IAUC70and CRP (p <0.05),and LDL-C,FBG,HbA1c,HOMA-IR,MAGE,LAGE,MODD and CRP (p <0.01).In contrast,levels of LDL-C and FMD were sig-nificantly lower in the two disease groups than in the NC group (p <0.01).Compared with pa-tients in the T2DM1group,those in the T2DM2group had higher levels MAGE,LAGE,MPPGE,MODD,IAUC70,CRP and lower level of FMD (p <0.01).A larger degree of blood glucose fluctuation was observed in the T2DM2group than in the T2DM1group and the NC group.Negative Correlation Between FDM and LAGE,MPPGE,MODD and IAUC70in T2DM2PatientsFDM decreased significantly in T2DM2pa-tients.In these patients,FDM was negatively cor-related with MAGE (p =0.003),LAGE (p =0.029),MPPGE (p =0.033),MODD (p =0.025)and IAUC70(p =0.042)(Table II).Inversely,CRP was positively correlated with MAGE (p =0.002),LAGE (p =0.001),MPPGE (p =0.010),MODD (p =0.020)and IAUC70(p =0.182);HOMA-IR was positively correlated with MAGE (p =0.025),LAGE (p =0.013),MPPGE and MODD (p =0.045).No significant correlation between HbA1c and the blood glu-cose fluctuation was detected (Table II).Taken together,these observations suggest that bloodsions (LAGE),mean postprandial glycemic ex-cursions (MPPGE),absolute means of daily dif-ferences (MODD),incremental area under the curve below 70mg/dl (IAUC 70),endothelium-dependent flow-mediated dilation (FMD),and C-reaction protein (CRP)were extracted and analyzed using the CGMS system solutions software (MMT-7310Version 3.0C 3.0.128).Brachial Artery FMD ExaminationBrachial artery FMD examination was carried out following fasting or low-fat diet for 8-12h during the course of CGM.Patients were told not to drink coffee or tea at least 2h before the exam-ination.Vasoactive drugs,antihypertensive drugs,nitrates and statins drugs were also avoided for at least3days before the test.The test was per-formed in a quiet environment at a comfortable temperature (18to 24°C).BP (blood pressure)was monitored during a 20min supine rest.The process of pressurization was performed by a spe-cialized nurse using an electric pressure pump.Ultrasonic examination was performed using a high-resolution ultrasound system (ProSound α10,Aloka,Tokjo,Japan)with a 13-Hz probe,which was placed 2-5cm above the elbow to de-tect brachial artery.The depth of investigation was adjusted so that the boundaries of the vessel lumen and vessel wall were clearly distinguish-able in the longitudinal section image.The base-line value of the internal diameter of the brachial artery was recorded and referred to as D 0(mm).Reactive hyperemia was induced by rapid pres-surization to 300mmHg for 5min.The peak val-ue of the internal diameter of the brachial artery after releasing was recorded and referred to as D 1(mm).FMD =(D1-D0)/D0×100%.Statistical AnalysisStatistical analysis was performed using SPSS 16.0software (SPSS Inc.,Chicago,IL,USA).Data were expressed as mean ±standard devia-tion and analyzed by Student’s t -test,one-way ANOV A,Pearson correlation analysis or multi-variate regression analysis.Results were consid-ered significant when p <0.05.ResultsA total of 88T2DM patients were enrolled in the study.Of them,36(16male,20female)did not have CHD and were allocated to T2DM1group and 52(26male,26female)had CHD and3596glucose fluctuation might be a result of changes in FMD,CRP and HOMA-IR in T2DM patients with CHD.Relationship Among Multi-Variables in T2DM2PatientsWhen FMD was considered as the dependent variable,it could be calculated using the follow-ing regression equation:FMD =11.217-0.369MAGE-0.346(HOMA-IR)-0.447SBP (Table III).When CRP was chosen as the dependent variable,the regression equation was as follows:CRP =3.527+0.566LAGE (Table IV).These further suggest that FMD was strongly correlated with MAGE,HOMA-IR and SBP while CRP was strongly correlated with LAGE.DiscussionThe effect of blood glucose fluctuation on the function of vascular endothelial cells has become a subject of extensive research in recent years.It is reported that postprandial hyperglycemia is anX.-G.Zhang,Y .-Q.Zhang,D.-K.Zhao,J.-X.Wu,J.Zhao,X.-M.Jiao,B.Chen,X.-F .LvTable I.Clinical characteristics,CGMS parameters and FMD in the three study groups.aMeasured by continuous glucose monitoring system;b Measured by high-resolution ultrasound system.*p <0.05;**p <0.01:compared with NC group;#p <0.05;##p <0.01:compared with T2DM1group.Table II.Correlations between the indicated variables in T2DM2group.aMeasured by continuous glucose monitoring system;b Measured by high-resolution ultrasound system.independent predictor of cardiovascular events and death in diabetic patients 18.Moreover,it has been shown that postprandial hyperglycemia is a risk factor for patients with or without diagnosed by diabetes 19.In our study,brachial artery FMD in patients with T2DM was significantly de-creased compared with healthy control subjects.Correlation analysis showed that FMD was cor-related with TG,SBP,HbA1c and blood glucose fluctuation.This suggests that decreased brachial artery FMD may be associated with aberrant glu-cose and lipid metabolism in patients with T2DM.Macrovascular complications occurred earlier in the T2DM2group than in the T2DM1group.Blood glucose fluctuation parameters (MAGE,LAGE,MODD,MPPGE and IAUC 70)in T2DM2patients were remarkably increased as compared with those in T2DM1patients.In other words,when the course of the disease,blood glu-cose,blood pressure,cholesterol and other fac-tors were controlled,increased blood glucose fluctuation became an important factor causes the decrease of brachial artery FMD in T2DM patients with CHD.Vascular dysfunction may result from blood glucose fluctuation,but the underlying mecha-nism remains unclear.Many studies indicated that oxidative stress play an important role in the process of vascular dysfunction caused by blood glucose fluctuation.Quagliaro et al 11have report-ed that temporary hyperglycemia accelerates the damage of vascular endothelial cells,and pro-motes apoptosis and oxidative DNA damage as compared with persistent hyperglycemia.Fur-thermore,in vivo studies have demonstrated that rapidly elevated glucose concentration may acti-vate P65subunit of NF-kB of arterial endothelial cells in non-diabetic rats,and elevated glucose concentration induce the expression of monocyte chemoattractant protein-1(MCP-1)and vascular cell adhesion molecule-l (VCAM-1).Inhibition of mitochondrial superoxide ion may attenuate the aberrant expression of these factors 20.In addi-tion to vascular endothelial cells,a variety of oth-er cell types including renal cortex fibroblast cells and human peripheral blood mononuclear cells can also be injured after intermittent high glucose exposure.Through analyzing changes in the intracellular nitrotyrosine and 8-hydroxy de-oxyguanosine (8-OHdG)expression and activity of Bcl-2and caspase-3,Piconi et al 21found in-termittent elevated blood glucose could induce endothelial cell apoptosis through reactive oxy-gen species (ROS)-associated oxidative stress.These observations indicate that oxidative stress is involved in blood glucose fluctuation.Previous clinical studies 22have reported that the excretion rate of 8-iso-prostaglandin F2alpha (8-isoPGF2α)is highly correlated with MAGE (r =0.86,p <0.001)but not the average blood glu-cose,fasting blood glucose or HbA1c.MAGE is considered to be the “gold standard”indicator of blood glucose fluctuation and 8-isoPGF2α(a peroxidation product)in vivo.The correlation be-tween these two factors suggest that oxidative stress may be an important mechanism underly-ing the blood glucose fluctuation-associated vas-cular injury.In the present study,MAGE was the variable that showed the strongest correlation with brachial artery FMD in T2DM2patients.It3597Blood glucose fluctuation in T2DM with CHDTable III.Results of multivariate regression analysis of factors affecting FMD in T2DM2 group.Table IV .Results of multiple regression analysis of factors affecting CRP in T2DM2 group.is possible that blood glucose fluctuation causes vascular endothelial injury through decreasing both NO synthesis and FMD. MAGE includes all valid blood glucose fluctuation indicators and, therefore, is closely related to endothelial func-tion in FMD. Parameters such as LAGE, MODD, MPPGE and IAUC70 were also correlated with FMD in the linear regression analysis but failed to perform the multivariate regression analysis. This might be due to the incomprehensive repre-sentativeness of these parameters to blood glu-cose fluctuation.Another potential mechanism is the inflamma-tion hypothesis. It is believed that type 2 diabetes is a chronic inflammatory disease. Our study found that CRP was significantly higher in T2DM patients as compared to healthy control subjects. This observation is consistent with re-sults from previous studies23-25. CRP can cause vascular endothelial dysfunction in a variety of ways26,27. To date, it remains inconclusive regard-ing whether blood glucose fluctuation plays a role in increasing inflammation in T2DM pa-tients. Tanaka et al28reported that postprandial hyperglycemia could increase IL-L and TNF-αin peripheral blood. And excessive secretion of IL-1 and TNF-αcan increase CRP synthesis29, which indicating that blood glucose fluctuation may lead to increased inflammatory factors such as IL-l, TNF-αand CRP. In this study, the CRP level was apparently increased in T2DM patients, particularly those with CHD as compared with control subjects. Correlation analysis showed that CRP was correlated with MAGE, LAGE, MPPGE, and MODD. The maximal correlation coefficient was obtained between LAGE and CRP, indicating that an increase in CRP may be related to excessive blood glucose drift in T2DM patients with CHD. LAGE was the maximal acute fluctuation during the entire observation period (24 hours) and CRP is an acute phase pro-tein. Our findings showed that increased blood glucose fluctuation could decrease the brachial artery FMD and elevate CRP in T2DM patients with CHD. This indicates that elevated CRP may be one of the mechanisms responsible for vascu-lar endothelial dysfunction in T2DM patients with CHD.In addition to blood glucose fluctuation, HOMA-IR was another important factor that af-fected the brachial artery FMD in T2DM patients with CHD. Insulin-dependent phosphatidylinosi-tol 3 kinase (PI-3K) signal transduction pathway regulates the expression of endothelial nitric ox-ide synthase (eNOS) gene30, thereby regulating NO production. IR leads to injuries of endothe-lial cells in many ways while damaged endothe-lial cells may exacerbate IR by changing the dis-tribution and function of insulin receptors on the cell surface.Furthermore, this study showed that in T2DM patients with CHD, systolic blood pressure was one of the important factors that affect brachial artery FMD in addition to blood glucose fluctua-tions. Woodman et al31found that there was a significant increase in CRP and von willebrand facotr (vWF) in T2DM patients with hyperten-sion. And von Willebrand Factor (vWF) is an im-portant indicator of vascular endothelial function. This indicates an endothelial dysfunction in T2DM patients with hypertension. The United Kingdom Prospective Diabetes Study (UKPDS) has demonstrated that a strict control of blood pressure may reduce the incidence of vascular complications in T2DM patients32. Elevated sys-tolic blood pressure is commonly seen in elderly patients. An increase in blood pressure may lead to injury of vascular endothelial cells of the af-fected vessels through a flow-associated mechan-ical mechanism. In addition, high blood pressure may cause endothelial cell dysfunction through insufficient L-arginine (NO precursors), NO in-activation induced by increased superoxide anion generation, activation of vascular renin-an-giotensin-aldosterone system (RAS), and imbal-ance of NO/ET-1 synthesized by endothelial cells33. The relationship between systolic blood pressure and brachial artery FMD in our study might result from a mechanical stimulation and the interaction of FMD with the vascular en-dothelial cells.ConclusionsThis study demonstrated that blood glucose fluctuation increased significantly in T2DM pa-tients with CHD as compared with those without CHD. Blood glucose fluctuation was found to be an important factor that affected the brachial artery FMD, possibly through a CRP elevation-associat-ed mechanism. Moreover, IR and systolic blood pressure were also important factors that could af-fect brachial artery FMD. All these observations suggest that vascular endothelial dysfunction in T2DM patients with CHD may be protected through an effective control of blood pressure and extenuation of blood glucose fluctuation.X.-G. Zhang, Y.-Q. Zhang, D.-K. Zhao, J.-X. Wu, J. Zhao, X.-M. Jiao, B. Chen, X.-F. Lv3598–––––––––––––––––-––––Conflict of InterestThe Authors declare that there are no conflicts of interest.References1)T EMELKOVA-K URKTSCHIEV TS, K OEHLER C, H ENKEL E,L EONHARDT W, F UECKER K, H ANEFELD M.Postchal-lenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830-1834.2)A ZUMA K, K AWAMORI R, T OYOFUKU Y, K ITAHARA Y, S ATOF, S HIMIZU T, M IURA K, M INE T, T ANAKA Y, M ITSUMATA M, W ATADA H. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Bi-ol 2006; 26: 2275-2280.3)T ORIMOTO K, O KADA Y, M ORI H, T ANAKA Y. Relation-ship between fluctuations in glucose levels mea-sured by continuous glucose monitoring and vas-cular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 2013; 12: 1.4)DCCT R ESEARCH G ROUP.The relationship ofglycemic exposure (HbA1c) to the risk of develop-ment and progression of retinopathy in the dia-betes control and complications trial. Diabetes 1995; 44: 968-983.5)J IAO X M, Z HANG X G, X U X U, Y I C, B IN C, C HENG QP, G ONG Q Q, L V X F. Blood glucose fluctuation aggravates lower extremity vascular disease in type 2 diabetes. Eur Rev Med Pharmacol Sci 2014; 18: 2025-2030.6)S ERVICE FJ, M OLNAR GD, R OSEVEAR JW, A CKERMAN E,G ATEWOOD LC, T AYLOR WF. Mean amplitude ofglycemic excursions, a measure of diabetic insta-bility. Diabetes 1970; 19: 644-655.7)B LANES MG, O UBAHA M, R AUTUREAU Y, G RATTON JP.Phosphorylation of tyrosine 801 of vascular en-dothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide syn-thase activation and nitric oxide release from en-dothelial cells. J Biol Chem 2007; 282: 10660-10669.8)R ODBARD D. Interpretation of continuous glucosemonitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1): S55-67.9)Q UAGLIARO L, P ICONI L, A SSALONI R, M ARTINELLI L,M OTZ E, C ERIELLO A. Intermittent high glucose en-hances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.Diabetes 2003; 52: 2795-2804.10)P ICONI L, Q UAGLIARO L, D A R OS R, A SSALONI R,G IUGLIANO D, E SPOSITO K, S ZABO C, C ERIELLO A.Inter-mittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004; 2: 1453-1459.11)Q UAGLIARO L, P ICONI L, A SSALONI R, D A R OS R, M AIERA, Z UODAR G, C ERIELLO A. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin ex-pression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atheroscle-rosis 2005; 183: 259-267.12)S HI XL, R EN YZ, W U J. Intermittent high glucose en-hances apoptosis in INS-1 cells. Exp Diabetes Res 2011; 2011: 754673.13)M ASUMOTO A, T AKAMOTO N, M ASUYAMA H, A KAHORI Y,I NOUE S, H IRAMATSU Y. Effects of intermittent highglucose on BeWo choriocarcinoma cells in culture.J Obstet Gynaecol Res 2011; 37: 1365-1375. 14)L IAO J, L EI M, C HEN X, L IU F. Effect of intermittenthigh glucose on synthesis of nitric oxide in human umbilical vein endothelial cells and its mecha-nism. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010; 35: 295-300.15)A NDERSON TJ, U EHATA A, G ERHARD MD, M EREDITH IT,K NAB S, D ELAGRANGE D, L IEBERMAN EH, G ANZ P, C REA-GER MA, Y EUNG AC,et a L. Close relation of en-dothelial function in the human coronary and pe-ripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.16)Z HOU J, L I H, R AN X, Y ANG W, L I Q, P ENG Y, L I Y, G AOX, L UAN X, W ANG W, J IA W. Reference values for continuous glucose monitoring in Chinese sub-jects. Diabetes Care 2009; 32: 1188-1193.17)V AGUE J, V AGUE P, T RAMONI M, V IALETTES B, M ERCIERP. Obesity and diabetes. Acta Diabetol Lat 1980;17: 87-99.18)G AO W, Q IAO Q, T UOMILEHTO J.Post-challenge hy-perglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events. Clin Lab 2004; 50: 609-615.19)C ERIELLO A. Postprandial hyperglycemia and car-diovascular complications of diabetes. Journ An-nu Diabetol Hotel Dieu 2006: 75-78.20)E L-O STA A, B RASACCHIO D, Y AO D, P OCAI A, J ONES PL,R OEDER RG, C OOPER ME, B ROWNLEE M. Transient high glucose causes persistent epigenetic changes and altered gene expression during sub-sequent normoglycemia. J Exp Med 2008; 205: 2409-2417.21)P ICONI L, Q UAGLIARO L, A SSALONI R, D A R OS R, M AIERA, Z UODAR G, C ERIELLO A. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction.Diabetes Metab Res Rev 2006; 22: 198-203.22)M ONNIER L, M AS E, G INET C, M ICHEL F, V ILLON L,C RISTOL JP, C OLETTE C. Activation of oxidative stressby acute glucose fluctuations compared with sus-tained chronic hyperglycemia in patients with type2 diabetes. JAMA 2006; 295: 1681-1687.23)R ODRIGUEZ-M ORAN M, G UERRERO-R OMERO F.In-creased levels of C-reactive protein in noncon-trolled type II diabetic subjects. J Diabetes Com-plications 1999; 13: 211-215.24)A RNALICH F, H ERNANZ A, L OPEZ-M ADERUELO D, P ENAJM, C AMACHO J, M ADERO R, V AZQUEZ JJ, M ONTIEL C.3599Blood glucose fluctuation in T2 DM with CHD。

相关文档
最新文档